{"version":"1.0","type":"link","title":"Venetoclax and ibrutinib: Two partners for the front-line treatment of chronic lymphocytic leukemia.","author_name":"Visentin A 외","author_url":"https://prs-insight.online/author/Visentin%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/89983","thumbnail_width":1200,"thumbnail_height":630}